Unveiling Immune Infiltration Characterizing Genes in Hypertrophic Cardiomyopathy Through Transcriptomics and Bioinformatics

References

• Tuohy CV, Kaul S, Song HK, Nazer B, Heitner SB. Hypertrophic cardiomyopathy: the future of treatment. European J of Heart Fail. 2020;22(2):228–240. doi:10.1002/ejhf.1715
   PubMed Web of Science ®Google Scholar
• Owens AT, Cappola TP. Recreational exercise in hypertrophic cardiomyopathy. JAMA. 2017;317(13):1319. doi:10.1001/jama.2017.2584
   PubMed Web of Science ®Google Scholar
• Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am College Cardiol. 2015;65(12):1249–1254. doi:10.1016/j.jacc.2015.01.019
   PubMed Web of Science ®Google Scholar
• Wooten EC, Hebl VB, Wolf MJ, et al. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2013;6(1):10–18. doi:10.1161/CIRCGENETICS.112.965277
   PubMedGoogle Scholar
• Lang. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(4):412. doi:10.1093/ehjci/jew041
   PubMed Web of Science ®Google Scholar
• Ito T, Suwa M. Echocardiographic tissue imaging evaluation of myocardial characteristics and function in cardiomyopathies. Heart Fail Rev. 2021;26(4):813–828. doi:10.1007/s10741-020-09918-y
   PubMed Web of Science ®Google Scholar
• Maron BJ, Rowin EJ, Maron MS. Paradigm of sudden death prevention in hypertrophic cardiomyopathy. Circ Res. 2019;125(4):370–378. doi:10.1161/CIRCRESAHA.119.315159
   PubMed Web of Science ®Google Scholar
• Saparov A, Ogay V, Nurgozhin T, et al. Role of the immune system in cardiac tissue damage and repair following myocardial infarction. Inflamm Res. 2017;66(9):739–751. doi:10.1007/s00011-017-1060-4
   PubMed Web of Science ®Google Scholar
• Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995;92(4):785–789. doi:10.1161/01.CIR.92.4.785
   PubMed Web of Science ®Google Scholar
• Chen CY, Lin LY, Lin YH, et al. P5269The impact of sarcomeric mutations on myocardial fibrosis and ventricular diastolic function in hypertrophic cardiomyopathy (SADS-TW HCM registry study). Euro Heart J. 2019;40(Supplement_1):ehz746. doi:10.1093/eurheartj/ehz746.0240
   Google Scholar
• Fumagalli C, Fedele E, Beltrami M, et al. P1243Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy. Euro Heart J. 2019;40(Supplement_1):ehz748. doi:10.1093/eurheartj/ehz748.0201
   Google Scholar
• Van Den Akker F, Deddens JC, Doevendans PA, Sluijter JPG. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. Biochimica et Biophysica Acta. 2013;1830(2):2449–2458. doi:10.1016/j.bbagen.2012.08.026
   PubMed Web of Science ®Google Scholar
• Imanaka‐Yoshida K. Inflammation in myocardial disease: from myocarditis to dilated cardiomyopathy. Pathol Int. 2020;70(1):1–11. doi:10.1111/pin.12868
   PubMed Web of Science ®Google Scholar
• Frantz S, Hofmann U, Fraccarollo D, et al. Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J. 2013;27(3):871–881. doi:10.1096/fj.12-214049
   PubMed Web of Science ®Google Scholar
• Bouchentouf M, Williams P, Forner KA, et al. Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. Blood. 2010;116(21):2786. doi:10.1182/blood.V116.21.2786.2786
   Web of Science ®Google Scholar
• Palomer X, Román-Azcona MS, Pizarro-Delgado J, et al. SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation. Sig Transduct Target Ther. 2020;5(1):14. doi:10.1038/s41392-020-0114-1
   PubMed Web of Science ®Google Scholar
• Lin YS, Chang TH, Ho WC, et al. Sarcomeres morphology and Z-line arrangement disarray induced by ventricular premature contractions through the Rac2/cofilin pathway. IJMS. 2021;22(20):11244. doi:10.3390/ijms222011244
   Google Scholar
• Shimada YJ, Raita Y, Liang LW, et al. Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity. Euro Heart J. 2021;42(Supplement_1):ehab724. doi:10.1093/eurheartj/ehab724.1777
   Google Scholar
• Talaat IM, Elemam NM, Abdullah HW. CD68, CD86 and CD163 expression profile in breast cancer molecular subtypes. THE FASEB J. 2022;36(S1):1. doi:10.1096/fasebj.2022.36.S1.R3106
   Google Scholar
• Ryabov V, Gombozhapova A, Rogovskaya Y, Kzhyshkowska J, Rebenkova M, Karpov R. Cardiac CD68+ and stabilin-1+ macrophages in wound healing following myocardial infarction: from experiment to clinic. Immunobiology. 2018;223(4–5):413–421. doi:10.1016/j.imbio.2017.11.006
   PubMed Web of Science ®Google Scholar
• Loi H, Kramar S, Laborde C, et al. Metformin attenuates postinfarction myocardial fibrosis and inflammation in mice. IJMS. 2021;22(17):9393. doi:10.3390/ijms22179393
   Google Scholar
• Motta M, Shelvin B, Lerner S, Keating M, Wierda WG. Increased Expression of CD152 by normal T lymphocytes in untreated patients with B cell chronic lymphocytic leukemia. Blood. 2004;104(11):963. doi:10.1182/blood.V104.11.963.963
   Google Scholar
• Psarras S, Beis D, Nikouli S, Tsikitis M, Capetanaki Y. Three in a box: understanding cardiomyocyte, fibroblast, and innate immune cell interactions to orchestrate cardiac repair processes. Front Cardiovasc Med. 2019;6:32. doi:10.3389/fcvm.2019.00032
   PubMed Web of Science ®Google Scholar
• Cai D, Holm JM, Duignan IJ, et al. BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiological Genomics. 2006;24(3):191–197. doi:10.1152/physiolgenomics.00165.2005
   PubMed Web of Science ®Google Scholar
• Zhang L, Jain MK. Circadian regulation of cardiac metabolism. J Clin Invest. 2021;131(15):e148276. doi:10.1172/JCI148276
   PubMed Web of Science ®Google Scholar
• Young ME, Brewer RA, Peliciari-Garcia RA, et al. Cardiomyocyte-specific BMAL1 plays critical roles in metabolism, signaling, and maintenance of contractile function of the heart. J Biol Rhythms. 2014;29(4):257–276. doi:10.1177/0748730414543141
   PubMed Web of Science ®Google Scholar